(Q40823139)

24 September 2017

title

Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine (English)

1 reference

24 September 2017

0 references

Escherichia coli

1 reference

Hagiwar Y

1

1 reference

24 September 2017

Tsuji T

2

1 reference

24 September 2017

Iwasaki T

3

1 reference

24 September 2017

Kadowaki S

4

1 reference

24 September 2017

Asanuma H

5

1 reference

24 September 2017

Chen Z

6

1 reference

24 September 2017

Komase K

7

1 reference

24 September 2017

Suzuki Y

8

1 reference

24 September 2017

Aizawa C

9

1 reference

24 September 2017

Kurata T

10

1 reference

24 September 2017

Tamura S

11

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

19

1 reference

24 September 2017

issue

15-16

1 reference

24 September 2017

page(s)

2071-2079

1 reference

Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Construction of a plasmid for expression of foreign epitopes as fusion proteins with subunit B of Escherichia coli heat-labile enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Detection of Heat-Labile Escherichia coli Enterotoxin with the Use of Adrenal Cells in Tissue Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Measurement of antigen-specific mouse IgE by a fluorometric reverse (IgE-capture) ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Fluid accumulation in mouse ligated intestine inoculated with Clostridium perfringens enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Purification and partial characterization of heat-stable enterotoxin of enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900414-X

7 January 2021

10.1016/S0264-410X(00)00414-X

Identifiers

DOI

1 reference

24 September 2017

1 reference